참고문헌
- Mortality patterns--preliminary data, United States, 1996. MMWR Morb Mortal Wkly Rep 1997;46:941-4
- Michaud CM, Murray CJ, Bloom BR. Burden of disease-implications for future research. Jama 2001;285:535-9 https://doi.org/10.1001/jama.285.5.535
- Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117: 5S-9S https://doi.org/10.1378/chest.117.1.5
- BascomR. Differential susceptibility to tobacco smoke:possible mechanisms. Pharmacogenetics 1991;1: 102-6 https://doi.org/10.1097/00008571-199111000-00008
- Redline S, Tishler PV, Lewitter FI, Tager IB, Munoz A, Speizer FE. Assessment of genetic and nongenetic influences on pulmonary function. A twin study. Am Rev Respir Dis 1987;135:217-22
- Givelber RJ, Couropmitree NN, Gottlieb DJ, Evans JC, Levy D, Myers RH, et al. Segregation analysis of pulmonary function among families in the Framingham Study. Am J Respir Crit Care Med 1998;157:1445-51 https://doi.org/10.1164/ajrccm.157.5.9704021
- Black LF, Kueppers F. alpha1-Antitrypsin deficiency in nonsmokers. Am Rev Respir Dis 1978;117:421-8
- O'Brien ML, Buist NR, Murphey WH. Neonatal screening for alpha1-antitrypsin deficiency. J Pediatr 1978;92:1006-10. https://doi.org/10.1016/S0022-3476(78)80388-6
- Silverman EK. Genetic Epidemiology of COPD. Chest 2002;121:1S-6S https://doi.org/10.1378/chest.121.1.11
- Sandford AJ, Silverman EK. Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction. Thorax 2002;57:736-41 https://doi.org/10.1136/thorax.57.8.736
- Medzhitov R, Janeway CA, Jr. Innate immunity: the virtues of a nonclonal systemof recognition. Cell 1997;91:295-8 https://doi.org/10.1016/S0092-8674(00)80412-2
- Medzhitov R, Janeway C, Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000;173:89-97 https://doi.org/10.1034/j.1600-065X.2000.917309.x
- Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, FitzGerald MX, et al. Matrix metallo-proteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997;156:240-7 https://doi.org/10.1164/ajrccm.156.1.9612018
- Finlay GA, Russell KJ, McMahon KJ, D'Arcy E M, Masterson JB, FitzGerald MX, et al. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 1997;52:502-6 https://doi.org/10.1136/thx.52.6.502
- Betsuyaku T, Nishimura M, Takeyabu K, Tanino M, Venge P, Xu S, et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with sub-clinical emphysema. Am J Respir Crit Care Med 1999;159:1985-91 https://doi.org/10.1164/ajrccm.159.6.9809043
- Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000;117:684-94 https://doi.org/10.1378/chest.117.3.684
- Vazquez de Lara LG, Umstead TM, Davis SE, Phelps DS. Surfactant protein A increases matrix metalloproteinase-9 production by THP-1 cells. Am J Physiol Lung Cell Mol Physiol 2003;285:L899-906 https://doi.org/10.1152/ajpcell.00110.2003
- Yim JJ, Ding L, A.A. S, Park GY, Shim YS, Holland SM. A microsatellite polymorphism in intron 2 of human toll-like receptor 2: Functional Implications and Racial Differences. FEMS Immunol Med Biol 2004;(In press)
- McGinnis RE, Spielman RS. Insulin gene 5' flanking polymorphism. Length of class 1 alleles in number of repeat units. Diabetes 1995;44:1296-302 https://doi.org/10.2337/diabetes.44.11.1296
- Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, et al. Microsatellite poly-morphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000;66:187-95 https://doi.org/10.1086/302729
- Bartmann K, Fooke-Achterrath M, Koch G, Nagy I, Schutz I, Weis E, et al. Heterozygosity in the Pisystemas a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD). Eur J Respir Dis 1985;66:284-96
- Seersholm N, Wilcke JT, Kok-Jensen A, Dirksen A. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ. Am J Respir Crit Care Med 2000;161:81-4 https://doi.org/10.1164/ajrccm.161.1.9812131
- Kalsheker NA, Watkins GL, Hill S, Morgan K, Stockley RA, Fick RB. Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease. Dis Markers 1990;8:151-7
- Poller W, Meisen C, Olek K. DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur J Clin Invest 1990;20:1-7
- Poller W, Faber JP, Scholz S, Weidinger S, Bartholome K, Olek K, et al. Mis-sense mutation of alpha 1-anti-chymotrypsin gene associated with chronic lung disease. Lancet 1992;339:1538
- Smith CA, Harrison DJ. Association between poly-morphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997;350:630-3 https://doi.org/10.1016/S0140-6736(96)08061-0
- Harrison DJ, Cantlay AM, Rae F, Lamb D, Smith CA. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 1997;16:356-60 https://doi.org/10.1177/096032719701600703
- Baranova H, Perriot J, Albuisson E, Ivaschenko T, Baranov VS, Hemery B, et al. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet 1997;99:822-6 https://doi.org/10.1007/s004390050455
- Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, et al. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999;54:693-6 https://doi.org/10.1136/thx.54.8.693
- Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, 6. Givelber RJ, Couropmitree NN, Gottlieb DJ, Evans JC, Levy D, Myers RH, et al. Segregation analysis of pulmonary function among families in the Framingham Study. Am J Respir Crit Care Med 1998;157:1445-51 https://doi.org/10.1164/ajrccm.157.5.9704021
- Alvarez-Granda L, Cabero-Perez MJ, Bustamante-Ruiz A, Gonzalez-Lamuno D, Delgado-Rodriguez M, Garcia-Fuentes M. PI SZ phenotype in chronic obstructive pulmonary disease. Thorax 1997; 52: 659-61 https://doi.org/10.1136/thx.52.7.659
- Benetazzo MG, Gile LS, Bombieri C, Malerba G, Massobrio M, Pignatti PF, et al. alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. Respir Med 1999;93:648-54 https://doi.org/10.1016/S0954-6111(99)90105-1
- Morgan K, Scobie G, Kalsheker NA. Point mutation in a 3' flanking sequence of the alpha-1-antitrypsin gene associated with chronic respiratory disease occurs in a regulatory sequence. Hum Mol Genet 1993;2:253-7 https://doi.org/10.1093/hmg/2.3.253
- Sandford AJ, Chagani T, Weir TD, Pare PD. Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease. Dis Markers 1998; 13:257-60 https://doi.org/10.1155/1998/867620
- Yim JJ, Park GY, Lee CT, Kim YW, Han SK, Shim YS, et al. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 2000;55:121-5 https://doi.org/10.1136/thorax.55.2.121
- Yim JJ, Yoo CG, Lee CT, Kim YW, Han SK, Shim YS. Lack of association between glutathione S-trans-ferase P1 polymorphism and COPD in Koreans. Lung 2002;180:119-25 https://doi.org/10.1007/s004080000086
- Higham MA, Pride NB, Alikhan A, Morrell NW. Tumour necrosis factor-alpha gene promoter poly-morphism in chronic obstructive pulmonary disease. Eur Respir J 2000;15:281-4 https://doi.org/10.1034/j.1399-3003.2000.15b10.x
- Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999;26:1-3 https://doi.org/10.1046/j.1365-2370.1999.00122.x
- Khani-Hanjani A, Lacaille D, Hoar D, Chalmers A, Horsman D, Anderson M, et al. Association between dinucleotide repeat in non-coding region of interferongamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 2000;356:820-5 https://doi.org/10.1016/S0140-6736(00)02657-X
- Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow trans-plantation. Blood 2001;98:1594-600 https://doi.org/10.1182/blood.V98.5.1594
- Dabora SL, Roberts P, Nieto A, Perez R, Jozwiak S, Franz D, et al. Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. Am J Hum Genet 2002;71:750-8 https://doi.org/10.1086/342718
- Masutani K, Miyake K, Nakashima H, Hirano T, Kubo M, Hirakawa M, et al. Impact of interferongamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Am J Kidney Dis 2003;41:371-9 https://doi.org/10.1053/ajkd.2003.50046
- Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, et al. Microsatellite poly-morphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000;66:187-95 https://doi.org/10.1086/302729
- Benjafield AV, Wang XL, Morris BJ. Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease. J Mol Med 2001;79:109-15 https://doi.org/10.1007/s001090000168
- Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998;338:640-4 https://doi.org/10.1056/NEJM199803053381002
- Gebhardt F, Zanker KS, Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem 1999;274:13176-80 https://doi.org/10.1074/jbc.274.19.13176
- Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2001;2:10-9 https://doi.org/10.1186/rr33
- Minematsu N, Nakamura H, Tateno H, Nakajima T, Yamaguchi K. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 2001;289:116-9 https://doi.org/10.1006/bbrc.2001.5936
- Sethi S. Bacterial infection and the pathogenesis of COPD. Chest 2000;117:286S-91S https://doi.org/10.1378/chest.117.5_suppl_1.286S
- Hass H, Morris JF, Samson S, Kilbourn JP, Kim PJ. Bacterial flora of the respiratory tract in chronic bronchitis: comparison of transtracheal, fiberbron-choscopic, and oropharyngeal sampling methods. Am Rev Respir Dis 1977;116:41-7
- Read RC, Wilson R, Rutman A, Lund V, Todd HC, Brain AP, et al. Interaction of nontypable Haemo-philus influenzae with human respiratory mucosa in vitro. J Infect Dis 1991;163:549-58 https://doi.org/10.1093/infdis/163.3.549
- Von Hertzen L, Alakarppa H, Koskinen R, Liippo K, Surcel HM, Leinonen M, et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 1997;118:155-64 https://doi.org/10.1017/S095026889600725X
- Adler KB, Hendley DD, Davis GS. Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways. Am J Pathol 1986;125:501-14
- Li JD. Exploitation of host epithelial signaling net- works by respiratory bacterial pathogens. J Pharmacol Sci 2003;91:1-7 https://doi.org/10.1254/jphs.91.1
- Netea MG, Kullberg BJ, Galama JM, Stalenhoef AF, Dinarello CA, Van der Meer JW. Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways. Eur J Immunol 2002;32:1188-95 https://doi.org/10.1002/1521-4141(200204)32:4<1188::AID-IMMU1188>3.0.CO;2-A
- Flo TH, Ryan L, Latz E, Takeuchi O, Monks BG, Lien E, et al. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J Biol Chem 2002;277:35489-95 https://doi.org/10.1074/jbc.M201366200